Your browser doesn't support javascript.
loading
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.
Yndestad, Synnøve; Engebrethsen, Christina; Herencia-Ropero, Andrea; Nikolaienko, Oleksii; Vintermyr, Olav K; Lillestøl, Reidun K; Minsaas, Laura; Leirvaag, Beryl; Iversen, Gjertrud T; Gilje, Bjørnar; Blix, Egil S; Espelid, Helge; Lundgren, Steinar; Geisler, Jürgen; Aase, Hildegunn S; Aas, Turid; Gudlaugsson, Einar G; Llop-Guevara, Alba; Serra, Violeta; Janssen, Emiel A M; Lønning, Per E; Knappskog, Stian; Eikesdal, Hans P.
Afiliación
  • Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Engebrethsen C; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Herencia-Ropero A; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Vintermyr OK; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Lillestøl RK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Minsaas L; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Leirvaag B; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
  • Iversen GT; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Gilje B; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Blix ES; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Espelid H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Lundgren S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Geisler J; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Aase HS; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Aas T; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Gudlaugsson EG; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Llop-Guevara A; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
  • Serra V; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
  • Janssen EAM; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Lønning PE; Department of Surgery, Haugesund Hospital, Haugesund, Norway.
  • Knappskog S; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Eikesdal HP; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
JCO Precis Oncol ; 7: e2300338, 2023 Sep.
Article en En | MEDLINE | ID: mdl-38039432

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos